• T. Borikun R.E. Kavetsky Institute of Experimental Pathology, Oncology, and Radiobiology, NAS of Ukraine, Kyiv, Ukraine
  • O. Mushii R.E. Kavetsky Institute of Experimental Pathology, Oncology, and Radiobiology, NAS of Ukraine, Kyiv, Ukraine
  • A. Pavlova R.E. Kavetsky Institute of Experimental Pathology, Oncology, and Radiobiology, NAS of Ukraine, Kyiv, Ukraine
  • T. Burda R.E. Kavetsky Institute of Experimental Pathology, Oncology, and Radiobiology, NAS of Ukraine, Kyiv, Ukraine
  • T. Zadvornyi R.E. Kavetsky Institute of Experimental Pathology, Oncology, and Radiobiology, NAS of Ukraine, Kyiv, Ukraine




prostate cancer, miR-7-5p, miR-19a-3p, miR-23b-3p, risk of progression, tumor microenvironment


Background. The tumor microenvironment (TME) plays an important role in the occurrence and progression of prostate cancer (PCa). At the same time, the mechanisms and features of the interaction between tumor cells and individual components of the TME in PCa remain not fully elucidated. The aim was to study the expression levels of tumor-associated miR-7-5p, miR-19a-3p, and miR-23b-3p in the PCa tissue and to analyze their relationship with the features of TME. Materials and Methods. The work is based on the analysis of the results of the examination and treatment of 50 patients with PCa of stages II—IV. The expression of miRNA in the PCa tissue was analyzed by the real-time polymerase chain reaction. The expression of alpha-smooth muscle actin (α-SMA), vimentin (VIM), and CD68 in PCa tissue was determined by the immunohistochemical method. The identification of mast cells in the PCa tissue was assessed by the histochemical method. Results. The analysis of the expression levels of tumor-associated miRNAs demonstrated that the tumor tissue of patients with a high risk of PCa progression was characterized by 4.93 (p < 0.01) and 8.97 (p < 0.05) times higher levels of miR-19a-3p and miR-23b-3p, respectively, compared to similar indicators in the group of patients with a low risk of PCa progression. The levels of miR-7-5p and miR-19a-3p expression in the PCa tissue correlated with the expression level of α-SMA (r = 0.49 and r = 0.45, respectively; p < 0.05) and VIM (r = 0.45 and r = 0.46; respectively, p < 0.05). A direct relationship (r = 0.44; p < 0.05) was established between the level of miR-7-5p expression and the degree of infiltration of the prostate gland tissue by tumor-associated macrophages. Conclusions. The features of the expression of tumor-associated miR-7-5p, miR-19a-3p, and miR-23b-3p indicated the prospect of their use as markers of the aggressiveness of the PCa course.


Baghban R, Roshangar L, Jahanban-Esfahlan R, et al. Tumor microenvironment complexity and therapeutic implications at a glance. CCS. 2020;18:1-19. https://doi.org/10.1186/s12964-020-0530-4

Li X, Wu Z, Fu X, Han W. A microRNA component of the neoplastic microenvironment: microregulators with far-reaching impact. BioMed Res Int. 2013;2013:762183. https://doi.org/10.1155/2013/762183

Pan Z, Tian Y, Niu G, Cao C. Role of microRNAs in remodeling the tumor microenvironment (Review). Int J Oncol. 2020;56(2):407-416. https://doi.org/10.3892/ijo.2019.4952

Gujrati H, Ha S, Wang BD. Deregulated microRNAs involved in prostate cancer aggressiveness and treatment resistance mechanisms. Cancers (Basel). 2023;15:3140. https://doi.org/10.3390/cancers15123140

Ghamlouche F, Yehya A, Zeid Y, et al. MicroRNAs as clinical tools for diagnosis, prognosis, and therapy in prostate cancer. Transl Oncol. 2023;28:101613. https://doi.org/10.1016/j.tranon.2022.101613

Yang N, Zhu S, Lv X, et al. MicroRNAs: pleiotropic regulators in the tumor microenvironment. Front Immunol.

;9:2491. https://doi.org/10.3389/fimmu.2018.02491

Eichmüller SB, Osen W, Mandelboim O, Seliger B. Immune modulatory microRNAs involved in tumor attack and tumor immune escape. J Natl Cancer Inst. 2017;109(10): djx034. https://doi.org/10.1093/jnci/djx034

Mansoori B, Baradaran B, Nazari A, et al. MicroRNAs in the cancer cell-to-cell communication: An insight into biological vehicles. Biomed Pharmacother. 2022;153:113449. https://doi.org/10.1016/j.biopha.2022.113449

Bertoli G, Cava C, Castiglioni I. MicroRNAs as biomarkers for diagnosis, prognosis and theranostics in prostate cancer. Int J Mol Sci. 2016:17:421. https://doi.org/10.3390/ijms17030421

Larne O, Martens-Uzunova E, Hagman Z, et al. miQ-A novel microRNA based diagnostic and prognostic tool for prostate cancer. Int J Cancer. 2012;132(12):2867-2875. https://doi.org/10.1002/ijc.27973

Suer I, Guzel E, Karatas OF, et al. MicroRNAs as prognostic markers in prostate cancer. Prostate. 2019;79:265- 271. https://doi.org/10.1002/pros.23731

Zadvornyi T, Mushii O, Borikun T, Lukianova N. Prostate cancer microenvironment-derived miRNAs as promis- ing biomarkers of progression disease. In 16th Annual Meeting Korean Soc Med Oncol & 2023 Int Conf. Seoul, Korea, Sep. 7–8, 2023. Abstract book: P228.

Brierley JD, Gospodarowicz MK, Wittekind C. (Eds.). TNM Classification of Malignant Tumours. John Wiley & Sons. 2017.

Epstein JI, Egevad L, Amin MB, et al. The 2014 International society of urological pathology (ISUP) consensus conference on Gleason grading of prostatic carcinoma: definition of grading patterns and proposal for a new grading system. Am J Surg Pathol. 2016;40:244-252.

Mottet N, Cornford P, van den Bergh RCN, et al. EAU – EANM – ESTRO – ESUR – ISUP – SIOG guidelines on prostate cancer. Update 2021. Available at: http://uroweb.org/guideline/prostate-cancer/

Zhang JD, Ruschhaupt M, Biczok R. ddCt method for qRT–PCR data analysis. Citeseer 2013;48(4):346-356.

Enerback L, Miller HRP, Mayrhofer G. Methods for the identification and characterization of mast cells by light microscopy. In: Befus D, Bienenstock J, eds. Mast Cell Differentiation and Heterogeneity. New York, USA: Raven Press, 1986:167-181.

Zhang Y, Nojima S, Nakayama H, et al. Characteristics of normal stromal components and their correlation with cancer occurrence in human prostate. Oncology Rep. 2003;10(1):207-211. https://doi.org/10.3892/or.10.1.207

Zhang SC, Hu ZQ, Long JH, et al. Сlinical implications of tumor-infiltrating immune cells in breast cancer. J Cancer. 2019;10(24):6175-6184. https://doi.org/10.7150/jca.35901

Fridman WH, Galon J, Dieu-Nosjean MC, et al. Immune infiltration in human cancer: prognostic significance and disease control. Curr Top Microbiol Immunol. 2011;344:1-24. https://doi.org/10.1007/82_2010_46

Wu W, Wang X, Le W, et al. Immune microenvironment infiltration landscape and immune-related subtypes in prostate cancer. Front Immunol. 2023;13:1001297. https://doi.org/10.3389/fimmu.2022.1001297

Chang M, He Y, Liu C, et al. Downregulation of SEPTIN5 inhibits prostate cancer progression by increasing CD8+ T cell infiltration. Int J Biol Sci. 2022;18(16):6035-6051. https://doi.org/10.7150/ijbs.76573

Gwak J, Jeong H, Lee K, et al. SFMBT2-mediated infiltration of preadipocytes and TAMs in prostate cancer. Cancers (Basel). 2020;12(9):2718. https://doi.org/10.3390/cancers12092718

Zadvornyi T, Lukianova N, Borikun T, et al. Mast cells as a tumor microenvironment factor associated with the aggressiveness of prostate cancer. Neoplasma. 2022;69(6):1490-1498. https://doi.org/10.4149/neo_2022_ 221014N1020

Jaeschke A, Jacobi A, Lawrence MG, et al. Cancer-associated fibroblasts of the prostate promote a compliant and more invasive phenotype in benign prostate epithelial cells. Mater Today Bio. 2020;8:100073. https://doi.org/10.1016/j.mtbio.2020.100073

Naleskina LA, Lukianova NY, Zadvornyi TV, et al. Remodeling the architecture of collagen-containing connective tissue fibers of metastatic prostate cancer. Cytol Genet. 2023;57:406-412. https://doi.org/10.3103/S0095452723050031

Santos JI, Teixeira AL, Dias F, et al. Influence of peripheral whole-blood microRNA-7 and microRNA-221 high expression levels on the acquisition of castration-resistant prostate cancer: evidences from in vitro and in vivo studies. Tumour Biol. 2014;35(7):7105-7113. https://doi.org/10.1007/s13277-014-1918-9

Feng S, Zhu X, Fan B, et al. miR-19a-3p targets PMEPA1 and induces prostate cancer cell proliferation, migration and invasion. Mol Med Rep. 2016;13:4030-4038. https://doi.org/10.3892/mmr.2016.5033.

Lu K, Liu C, Tao T, et al. MicroRNA-19a regulates proliferation and apoptosis of castration-resistant prostate cancer cells by targeting BTG1. FEBS Lett. 2015;589(13):1485-1490. https://doi.org/10.1016/j.febslet.2015.04.037

Fu F, Wan X, Wang D, et al. MicroRNA-19a acts as a prognostic marker and promotes prostate cancer progression via inhibiting VPS37A expression. Oncotarget. 2017;9(2):1931-1943. https://doi.org/10.18632/oncotarget.23026

Cruz-Burgos M, Cortés-Ramírez SA, Losada-García A, et al. Unraveling the role of EV-Derived miR-150-5p in prostate cancer metastasis and its association with high-grade Gleason scores: implications for diagnosis. Cancers (Basel). 2023;15(16):4148. https://doi.org/10.3390/cancers15164148

Lv W, Liu S, Zhang Q, et al. Circular RNA CircCOL5A1 sponges the MiR-7-5p/Epac1 axis to promote the progression of keloids through regulating PI3K/Akt signaling pathway. Front Cell Dev Biol. 2021;9:626027. https://doi.org/10.3389/fcell.2021.626027

Tian S, Chen M, Wang B, et al. miR-7-5p promotes hepatic stellate cell activation by targeting fibroblast growth factor receptor 4. Gastroenterol Res Pract. 2020;2020:5346573. https://doi.org/10.1155/2020/5346573

Midgley AC, Bowen T, Phillips AO, Steadman R. MicroRNA-7 inhibition rescues age-associated loss of epidermal growth factor receptor and hyaluronan-dependent differentiation in fibroblasts. Aging Cell. 2014;13(2):235- 244. https://doi.org/10.1111/acel.12167

Lou X, Fu J, Zhao X, et al. MiR-7e-5p downregulation promotes transformation of low-grade follicular lymphoma to aggressive lymphoma by modulating an immunosuppressive stroma through the upregulation of FasL in M1 macrophages. J Exp Clin Cancer Res. 2020;39(1):237. https://doi.org/10.1186/s13046-020-01747-z

Blumer S, Fang L, Chen WC, et al. IPF-Fibroblast Erk1/2 Activity Is Independent from microRNA Cluster 17-92 but can be inhibited by treprostinil through DUSP1. Cells. 2021;10(11):2836. https://doi.org/10.3390/ cells10112836

Wa Q, Li L, Lin H, et al. Downregulation of miR-19a-3p promotes invasion, migration and bone metastasis via activating TNF β signaling in prostate cancer. Oncol Rep. 2018;39(1):81-90. https://doi.org/10.3892/or.2017.6096




How to Cite

Borikun, T., Mushii, O., Pavlova, A., Burda, T., & Zadvornyi , T. (2024). TUMOR MICROENVIRONMENT-ASSOCIATED miR-7-5p, miR-19a-3p, AND miR-23b-3p EXPRESSION IN PROSTATE CANCER WITH DIFFERENT PROGRESSION RISK. Experimental Oncology, 45(4), 432–442. https://doi.org/10.15407/exp-oncology.2023.04.432



Original contributions

Most read articles by the same author(s)

1 2 > >>